Detalhe da pesquisa
1.
Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis: proof-of-concept, partially-randomised, double-blind, placebo-controlled, dose-escalation trial.
J Infect Dis
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527849
2.
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.
J Clin Oncol
; 36(19): 1913-1921, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29498924